MKI67 and breast carcinoma: In breast cancer, TXNIP knockdown increased Ki-67 expression (a marker of cell proliferation) and decreased p27 (a cell cycle regulatory protein), leading to enhanced breast cancer cell growth in vitro and in vivo (64–66).